Sigurdsson is charged with leading the agency's digital offering to meet growing client demand.
Facebook's decision to reprioritise its news feed to favour "social interactions" over other forms of content may please its users but will be challenging for brands.
Pharma looks to Spark for pricing blueprint; Ipsen hires Amgen exec as CEO of North America; FDA could improve social-media approach, study finds
The founder of Stagwell has claimed digital marketing agencies are undervalued because investors still fail to appreciate how much digital communications and e-commerce are going to transform the economy.
Digital innovation in Japan, health-tech trends, and social media top the list.
Mallinckrodt to buy Sucampo for $1.2 billion; Amazon pushes digital advertising in 2018; WHO classifies gaming disorder as mental health condition
A study has found that channels certified by the Trustworth Accountability Group (TAG) had 83% less ad fraud than the broader industry average.
GroupM, the media investment arm of WPP, forecasts global ad growth of 4.3% in 2018, and predicts Google and Facebook will strengthen their stranglehold on digital advertising.
Facebook has formally outlined is advertising policies to its users but the industry feels the internet giant is offloading responsibility instead of stepping up.
Two point-of-care companies have received hundreds of millions of dollars in funding. One of them, Outcome Health, is facing allegations about padding data.
Like its consumer-products cousins, pharma marketers are exercising more discipline over online media. Will it yield similar results?
Some of the world's marketers have reported specific examples of where their digital advertising appeared alongside offensive and compromising content.
Too few of the billions of sites online are usable for disabled people, says AudioEye's CEO.
Images that "mirror the demographic profile of their target audience" perform best, according to an eye-tracking study from picture provider Shutterstock.
The chip-in-a-pill combines antipsychotic Abilify with an ingestible sensor made by Proteus.
FDA requires boxed warning for J&J's Invokana; Amazon to reportedly hire GM to enter pharmacy industry; WannCry ransomware affects some health organizations
Renee Rodgers is executive director and head of digital strategy for U.S. oncology at Novartis.
Lisa Flaiz is the former group product director of digital marketing at Janssen.
Bruno Villetelle is chief digital officer at Takeda Pharmaceutical.
Kristin Milburnis head of strategic partnerships and the digital acceleration lab at Novartis.
Matias Coo is director of digital marketing for Avanir.
Drugmakers again spent more on DTC advertising in 2016 than the year before.
Organizations are focusing on better ways to verify HCPs' digital identities.
The MM&M Transforming Healthcare Conference will be held May 1 in New York City.
At the very least, pharma marketers need to make sure they know the difference between search engine marketing and search engine optimization.
Drugmakers have flirted with these pilots or partnerships, but few have fully embraced partnerships with digital health startups.
There are dozens of players, including leaders like IBM Watson Health and Verily as well as smaller concerns, lining up to sell pharma access to some sort of data solution.
In short, CEOs can't be afraid to walk away from their most profitable line if another approach may lead to improved long-term outcomes.
When his mother suffered from ovarian cancer a decade ago, Robert Herjavec found himself frustrated by the quality of care she received.
Otsuka, Astellas, Takeda, and Daiichi Sankyo share a degree of adventurousness and forward-mindedness in the digital realm.